Target intelligence / Profile preview

Hemagglutinin protein, H5 subtype, Influenza A virus (H5)

Target
H5
Molecular classification
Glycoprotein, Viral envelope protein, Class I fusion protein
01

Overview

The Hemagglutinin protein, H5 subtype, of Influenza A virus is a trimeric glycoprotein spike on the viral envelope that mediates host cell attachment by binding to sialic acid-containing receptors, determining host specificity such as avian versus human cells. It undergoes a pH-triggered conformational change in the endosome, exposing a fusion peptide that drives merger of viral and host membranes, enabling genome release into the cell. The H5 subtype, prominent in highly pathogenic avian influenza like H5N1, features a globular head for receptor binding and a conserved stem for fusion, with mutations potentially enhancing mammalian transmission. This protein's variability across 18 HA subtypes drives antigenic drift and shift, complicating vaccine design and necessitating annual updates. As a key viral antigen, H5 hemagglutinin elicits neutralizing antibodies targeting the head to block binding or the stem for broader protection against fusion. Its role in pandemics, such as potential zoonotic jumps from birds to humans, underscores ongoing surveillance needs.

Other names
HAInfluenza A virus hemagglutinin H5H5 hemagglutinin
02

Biological functions

Receptor bindingMembrane fusionHost cell attachmentViral entry
03

Disease associations

Infection

Beyond the preview

Go deeper on Hemagglutinin protein, H5 subtype, Influenza A virus (H5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin protein, H5 subtype, Influenza A virus (H5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call